Jakub Tomczak (VU), in Folia and Medical Life Sciences News

Ewelina Weglarz-Tomczak, from the Swammerdam Institute for Life Sciences, together with Stanley Brul (Professor of molecular biology and microbial food safey) and Jakub Tomczak (VU, CI group) does research into an enzyme. The enzyme, i.e. the protein enabling some processes to be faster, is known as protease, PLpro.

06/25/2020 | 12:00 PM

Ewelina Weglarz-Tomczak, from the Swammerdam Institute for Life Sciences, together with Stanley Brul (Professor of molecular biology and microbial food safey) and Jakub Tomczak (VU, CI group) does research into an enzyme. The enzyme, i.e. the protein enabling some processes to be faster, is known as protease, PLpro. It turns small virus proteins into functional proteins, enabling a small part of a virus to develop further. PLpro from newly discovered SARS-CoV-2 is supposedly the essential viral enzyme that incapacitates the antiviral immune response and takes advantage of the host's immune system. Hence, the current understanding of the SARS-CoV-2 infectious process indicates that shutting off PLpro represents a viable strategy in halting the spread of the virus. To read more, click here for Folia and here for medical net news.